This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Junichi Nakazawa: Innovator in Pharmaceutical Chemistry
Introduction
Junichi Nakazawa is a notable inventor based in Hiromachi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of cephalosporin derivatives. His work has implications for the production of important pharmaceutical compounds.
Latest Patents
Junichi Nakazawa holds a patent for a process for preparing cephalosporin derivatives. This patent describes a method for synthesizing a 7-acylamino (or 7-amino)-3-(substituted thiomethyl)cephalosporin derivative or a carboxyl derivative thereof. The process involves heating the corresponding 7-acylamino (or 7-amino)-3-carbamoyloxymethylcephalosporanic acid with a thiol under conditions that minimize the presence of water. The resulting compounds are valuable as pharmaceuticals or intermediates in pharmaceutical production. One notable compound from this process is 7.alpha.-methoxy-3-(1-methyl-1H-tetrazol-5-yl)thiomethyl-7.beta.-(O-5-p-nitrobenzoylamino-5-carboxyvaleramido-3-cephem-4-carboxylic acid), which is a new compound and includes its salts and esters.
Career Highlights
Junichi Nakazawa is associated with Sankyo Company, Limited, where he has contributed to various innovative projects in pharmaceutical development. His expertise in cephalosporin derivatives has positioned him as a key figure in the field.
Collaborations
He has worked alongside notable colleagues such as Takeo Miyaoka and Masanao Kaneko, contributing to advancements in pharmaceutical research and development.
Conclusion
Junichi Nakazawa's work in the field of pharmaceutical chemistry, particularly with cephalosporin derivatives, showcases his innovative spirit and dedication to advancing medical science. His contributions continue to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
